Wellness & Tox Lab

South East, USA

Short Summary

Biostat Laboratories is a full service Tox & Blood Lab housed in a brand new 5,000 square ft building with state of the art equipment and strong technology infrastructure.


  • Existing call service selling ad on service to over 100,000 clients
  • All equipment validated
  • Strong/qualified medical director to run lab operation
  • Owner has plenty of skin in the game
  • Strong sells and marketing team already
Please note: Investing in early stage businesses involves risks, including illiquidity, lack of dividends, loss of investment and dilution, and it should be done only as part of a diversified portfolio. This platform is targeted solely at investors who are sufficiently sophisticated to understand these risks and make their own investment decisions. This information has not been approved as a financial promotion, and you must carry out your own due diligence.


Investment Raised
Previous Rounds N/A
Stage Pre-Startup/R&D
Investor Role

Want to pitch on Angel Investment Network?

It’s easy to create a pitch using our online form. Your pitch can be in front of our 191,297 investors before you know it.

Create New Account
Already have an account?

Similar Projects

37% raised

Top Healthcare Investment

Midwest, USA

Capstone Health Network is a top U.S. healthcare investment. We cut prescription drug costs and help people speak to doctors & mental health counselors from home 24/7/365 with no doctor bills, co-pays, or deductibles! 30-75% annual ROI potential!

US$ 600,000


US$ 10,000

Min per Investor

Global Pro
0% raised

New Rotator Cuff Product

North East, USA

We have issued patents for a new breakthrough technology that will greatly improve the standard of care for rotator cuff tears and at the same time reduce medical spending. This investment will bring this new product to the FDA for approval.

US$ 1,500,000


US$ 5,000

Min per Investor

80% raised

TCI Healthcare Software

South East, USA

Last year, 50% of all hospitals in the U.S. were penalized an average of $1.2 million each for failing to report patient satisfaction & quality of care data on time. TCI software products mitigate this exposure for as little as $395 p/mo.

US$ 500,000


US$ 25,000

Min per Investor

load one similar proposal